109 related articles for article (PubMed ID: 7513469)
1. Functional and morphologic characterization of renal subcapsular islet isografts in rats treated with FK 506.
Ueki M; Yasunami Y; Ryu S; Arima T; Ikeda S; Tanaka M
Transplant Proc; 1994 Apr; 26(2):740. PubMed ID: 7513469
[No Abstract] [Full Text] [Related]
2. Protection of mouse islet isografts from early transplantation damage by nicotinamide treatment of recipients.
Kenmochi T; Mullen Y; Miyamoto M; Stein E
Transplant Proc; 1994 Apr; 26(2):693. PubMed ID: 8171611
[No Abstract] [Full Text] [Related]
3. Protective effects of nicotinamide on renal subcapsular islet isografts with a marginal mass from sustained hyperglycemia in the streptozotocin-induced diabetic rats.
Nagai T; Yasunami Y; Nagata N; Ueki M; Ono J; Ikeda S
Transplant Proc; 1995 Dec; 27(6):3196-7. PubMed ID: 8539910
[No Abstract] [Full Text] [Related]
4. Effect of hyperglycemia and of one-week culture of islets on the revascularization of pancreatic islet isografts.
Mendola JF; Fernández-Alvarez J; Saenz A; Benarroch G; Fernández-Cruz L; Gomis R
Transplant Proc; 1994 Apr; 26(2):689-91. PubMed ID: 7513465
[No Abstract] [Full Text] [Related]
5. Adjuvant immunotherapy with Bacillus Calmette-Guerin prevents recurrence of diabetes in islet grafts transplanted into NOD mice.
Lakey JR; Warnock GL; Singh B; Rajotte RV
Transplant Proc; 1994 Apr; 26(2):736. PubMed ID: 8171632
[No Abstract] [Full Text] [Related]
6. The long-term metabolic function of intraportal and renal subcapsular islet isografts and the effect on glomerular basement membrane thickness in rats.
Leow CK; Gray DW; Morris PJ
Diabetologia; 1995 Sep; 38(9):1014-24. PubMed ID: 8591814
[TBL] [Abstract][Full Text] [Related]
7. Prevention of recurrent autoimmune islet transplant destruction by simultaneous kidney transplantation.
Bartlett ST; Dirden B; Schweitzer EJ; Sheffield C; Hadley GA
Transplant Proc; 1994 Apr; 26(2):737. PubMed ID: 8171633
[No Abstract] [Full Text] [Related]
8. Leflunomide, a potential immunosuppressant for pancreatic islet transplantation.
Guo Z; Chong AS; Shen J; Foster P; Sankary HN; McChesney L; Mital D; Jensik SC; Gebel H; Williams JW
Transplant Proc; 1997; 29(1-2):1296-7. PubMed ID: 9123314
[No Abstract] [Full Text] [Related]
9. Islet protective effect of pravastatin from nonspecific inflammation in mouse pancreatic islet isografts.
Arita S; Saul J; Joh S; Kasraie A; Atiya A; Une S; Ohtsuka S; Mullen Y
Transplant Proc; 1996 Apr; 28(2):924. PubMed ID: 8623465
[No Abstract] [Full Text] [Related]
10. Comparison of MHC-incompatible intraportal islet and vascularized whole-pancreas transplantation in the prehyperglycemic phase of autoimmune diabetes.
Nakai I; Oda T; Mitsuo M; Shimizu Y; Arakawa K; Oka T; Sutherland DE; Brayman KL
Transplant Proc; 1994 Apr; 26(2):738. PubMed ID: 8171634
[No Abstract] [Full Text] [Related]
11. Recurrence of diabetes in a short time after intraportal but not spleen subcapsular islet transplantation in rats.
Suzuki K; Aoyagi K; Ogawa Y; Katayama Y; Abe Y; Tazawa Y; Ishigame M; Kimura M; Takebe K
Transplant Proc; 1994 Apr; 26(2):684. PubMed ID: 8171610
[No Abstract] [Full Text] [Related]
12. Long-term survival of islet allografts in diabetic rats treated with FK 506.
Tze WJ; Tai J; Cheung SS; Murase N; Ricordi C; Starzl TE
Transplant Proc; 1991 Dec; 23(6):3208-10. PubMed ID: 1721411
[No Abstract] [Full Text] [Related]
13. Dose dependence of bacillus Calmette-Guerin on the prevention of autoimmune diabetes in syngeneic islet transplantation.
Lakey JR; Singh B; Warnock GL; Elliott JF; Rajotte RV
Transplant Proc; 1995 Dec; 27(6):3413. PubMed ID: 8540025
[No Abstract] [Full Text] [Related]
14. Diabetogenic effects of FK506 on renal subcapsular islet isografts in rat.
Ueki M; Yasunami Y; Ina K; Ryu S; Funakoshi A; Kamei T; Ikeda S
Diabetes Res Clin Pract; 1993 Apr; 20(1):11-9. PubMed ID: 7688276
[TBL] [Abstract][Full Text] [Related]
15. Long-term functional xenograft tolerance after intrathymic islet transplantation (Lewis rat-->B6 mouse).
Zeng Y; Bluestone JA; Ildstad ST; Torres MA; Montag AG; Thistlethwaite RJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):438-9. PubMed ID: 8438368
[No Abstract] [Full Text] [Related]
16. Protection of intrahepatic islet grafts from hyperglycemic toxicity by nicotinamide treatment.
Ueki M; Yasunami Y; Arima T; Motoyama K; Ikeda S; Tanaka M
Transplant Proc; 1995 Feb; 27(1):618. PubMed ID: 7879121
[No Abstract] [Full Text] [Related]
17. Successful intraportal islet transplantation reverses non-steroid-related insulin resistance in humans.
Luzi L; Socci C; Falqui L; Battezzati A; Secchi A; Perseghin G; Maffi P; Bianchi E; di Carlo V; Pozza G
Transplant Proc; 1994 Apr; 26(2):572. PubMed ID: 8171559
[No Abstract] [Full Text] [Related]
18. Causes of islet allograft primary nonfunction.
Liu M; Shapiro ME
Transplant Proc; 1995 Dec; 27(6):3205-7. PubMed ID: 8539915
[No Abstract] [Full Text] [Related]
19. FK 506--an effective immunosuppressant in achieving long-term functional islet allograft survival in diabetic rats.
Tze WJ; Tai J; Cheung SS; Ricordi C; Murase N; Starzl TE
Transplant Proc; 1992 Jun; 24(3):1034-6. PubMed ID: 1376509
[No Abstract] [Full Text] [Related]
20. Rat islet isograft function. Effect of graft volume and transplantation site.
van Suylichem PT; Strubbe JH; Houwing H; Wolters GH; van Schilfgaarde R
Transplantation; 1994 Apr; 57(7):1010-7. PubMed ID: 8165696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
